Caprihans India Limited (CAPRIHANS.BO)
BSE · INR · Basic Materials · Specialty Chemicals
₹95.65 (+4.99%) as of
Key statistics
- Market cap
- 1.40B
- EPS (TTM)
- -27.53
- Dividend yield
- 0.00%
- 52-week range
- 50.30 – 138.85
- Beta
- 0.77
- Revenue (TTM)
- 7.42B
- Profit margin
- -3.67%
- Volume
- 2.44k
About Caprihans India Limited
Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax, Zymax Tx, and Zymax PDP names; coldforming blister foils under the Venus, Venus PR, Venus SBC, Tropical Foil, Nutra Venus, and Vento Venus names; lidding blister foils under the Zeon, Zeon+, Zenith, Zeon+PR, Suppo Zenith, Zeon PR, Zeon D, Zeon X, and DESALU names; lidding foils under the Crispak AP-PT, Crispak PL, Crispak PP, and Crispak PT names; and laminates/sachet foils under the Lamiflex PAL and RAL brand names. Further, the company offers pharma packaging research services, including formulation stability studies, blister / foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit services. It exports its products. The company was incorporated in 1946 and is headquartered in Pune, India. Caprihans India Limited is a subsidiary of Bilcare Mauritius Limited.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Headquarters
- Pune, India
- Employees
- 537
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.